532 related articles for article (PubMed ID: 25473176)
21. Effects of a low FODMAP diet on gut microbiota in individuals with treated coeliac disease having persistent gastrointestinal symptoms - a randomised controlled trial.
Herfindal AM; van Megen F; Gilde MKO; Valeur J; Rudi K; Skodje GI; Lundin KEA; Henriksen C; Bøhn SK
Br J Nutr; 2023 Dec; 130(12):2061-2075. PubMed ID: 37272479
[TBL] [Abstract][Full Text] [Related]
22. A randomized, double-blinded, placebo-controlled clinical trial on Lactobacillus-containing cultured milk drink as adjuvant therapy for depression in irritable bowel syndrome.
Sarkawi M; Raja Ali RA; Abdul Wahab N; Abdul Rathi ND; Mokhtar NM
Sci Rep; 2024 Apr; 14(1):9478. PubMed ID: 38658619
[TBL] [Abstract][Full Text] [Related]
23. [Long-term probiotic administration for irritable bowel syndrome: a legal need].
Solovyeva OI; Nekrasova AS; Topalova IG; Ponomarenko VA; Tsurtsumiia DB; Ilyashevich IG
Ter Arkh; 2023 Oct; 95(8):679-685. PubMed ID: 38158905
[TBL] [Abstract][Full Text] [Related]
24. Age-related symptom and life quality changes in women with irritable bowel syndrome.
Tang YR; Yang WW; Liang ML; Xu XY; Wang MF; Lin L
World J Gastroenterol; 2012 Dec; 18(48):7175-83. PubMed ID: 23326122
[TBL] [Abstract][Full Text] [Related]
25. Two Lactobacilli strains as adjuvant therapy in the management of irritable bowel syndrome: a randomized control trial.
Shanshal SA; Alsaaty MH; Al-Qazaz H; Al-Zidan RN
Ceska Slov Farm; 2024; 72(5):233-241. PubMed ID: 38195431
[TBL] [Abstract][Full Text] [Related]
26. Two Lactobacilli strains as adjuvant therapy in the management of irritable bowel syndrome: a randomized control trial.
Shanshal SA; Alsaaty MH; Al-Qazaz H; Al-Zidan RN
Ceska Slov Farm; 2024; 73(1):233-241. PubMed ID: 38185646
[TBL] [Abstract][Full Text] [Related]
27. Assessing 'response' to the low-FODMAP diet in irritable bowel syndrome: Should we be reporting harder primary endpoints?
Conley TE; Parkes M; Moss S; Probert C
Clin Nutr; 2024 May; 43(5):1079-1086. PubMed ID: 38579370
[TBL] [Abstract][Full Text] [Related]
28. Clinical trial: A Mediterranean diet is feasible and improves gastrointestinal and psychological symptoms in irritable bowel syndrome.
Staudacher HM; Mahoney S; Canale K; Opie RS; Loughman A; So D; Beswick L; Hair C; Jacka FN
Aliment Pharmacol Ther; 2024 Feb; 59(4):492-503. PubMed ID: 37969059
[TBL] [Abstract][Full Text] [Related]
29. Management of irritable bowel syndrome in primary care: feasibility randomised controlled trial of mebeverine, methylcellulose, placebo and a patient self-management cognitive behavioural therapy website. (MIBS trial).
Everitt HA; Moss-Morris RE; Sibelli A; Tapp L; Coleman NS; Yardley L; Smith PW; Little PS
BMC Gastroenterol; 2010 Nov; 10():136. PubMed ID: 21087463
[TBL] [Abstract][Full Text] [Related]
30. Irritable bowel syndrome-like symptoms before and after bariatric surgery and association with short-chain fermentable carbohydrates consumption: an observational prospective study.
Van Ouytsel P; Piessevaux H; Szalai A; Loi P; Louis H
Acta Gastroenterol Belg; 2023; 86(2):288-297. PubMed ID: 37428161
[TBL] [Abstract][Full Text] [Related]
31. A nutritional approach for managing irritable bowel syndrome.
Bhesania N; Cresci GAM
Curr Opin Pediatr; 2017 Oct; 29(5):584-591. PubMed ID: 28737582
[TBL] [Abstract][Full Text] [Related]
32. Therapy of IBS: Is a Low FODMAP Diet the Answer?
Manning LP; Yao CK; Biesiekierski JR
Front Psychiatry; 2020; 11():865. PubMed ID: 33110411
[TBL] [Abstract][Full Text] [Related]
33. Placebos without deception: a randomized controlled trial in irritable bowel syndrome.
Kaptchuk TJ; Friedlander E; Kelley JM; Sanchez MN; Kokkotou E; Singer JP; Kowalczykowski M; Miller FG; Kirsch I; Lembo AJ
PLoS One; 2010 Dec; 5(12):e15591. PubMed ID: 21203519
[TBL] [Abstract][Full Text] [Related]
34. Human Milk Oligosaccharides Support Normal Bowel Function and Improve Symptoms of Irritable Bowel Syndrome: A Multicenter, Open-Label Trial.
Palsson OS; Peery A; Seitzberg D; Amundsen ID; McConnell B; Simrén M
Clin Transl Gastroenterol; 2020 Dec; 11(12):e00276. PubMed ID: 33512807
[TBL] [Abstract][Full Text] [Related]
35. Diet in irritable bowel syndrome: What to recommend, not what to forbid to patients!
Cozma-Petruţ A; Loghin F; Miere D; Dumitraşcu DL
World J Gastroenterol; 2017 Jun; 23(21):3771-3783. PubMed ID: 28638217
[TBL] [Abstract][Full Text] [Related]
36. Negative Events During Adulthood Are Associated With Symptom Severity and Altered Stress Response in Patients With Irritable Bowel Syndrome.
Parker CH; Naliboff BD; Shih W; Presson AP; Videlock EJ; Mayer EA; Chang L
Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2245-2252. PubMed ID: 30616026
[TBL] [Abstract][Full Text] [Related]
37. Gluten restriction in irritable bowel syndrome, yes or no?: a GRADE-assessed systematic review and meta-analysis.
Arabpour E; Alijanzadeh D; Sadeghi A; Khoshdel S; Hekmatdoost A; Kord-Varkaneh H; Abdehagh M
Front Nutr; 2023; 10():1273629. PubMed ID: 38024368
[TBL] [Abstract][Full Text] [Related]
38. Screening of probiotic strains to improve visceral hypersensitivity in irritable bowel syndrome by using in vitro and in vivo approaches.
Torres-Maravilla E; Carvalho FA; Holowacz S; Delannoy J; Lenoir L; Jacouton E; Barbut F; Langella P; Bermúdez-Humarán LG; Waligora-Dupriet AJ
Benef Microbes; 2024 Apr; 15(3):293-310. PubMed ID: 38677716
[TBL] [Abstract][Full Text] [Related]
39. Multidomain patient-reported outcomes of irritable bowel syndrome: exploring person-centered perspectives to better understand symptom severity scores.
Lackner JM; Jaccard J; Baum C
Value Health; 2013; 16(1):97-103. PubMed ID: 23337220
[TBL] [Abstract][Full Text] [Related]
40. Digesting the Impact of Diet on Irritable Bowel Syndrome (IBS): Exploring Solutions for Controlling IBS.
Sarvepalli SS; Vemula SL; Aramadaka S; Mannam R; Sankara Narayanan R; Bansal A; Yanamaladoddi VR
Cureus; 2023 Sep; 15(9):e45279. PubMed ID: 37846263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
